Canntab Therapeutics Limited Stock Price on November 25, 2024

CTABF Stock  USD 0.0001  0.00  0.00%   
If you're considering investing in Canntab Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Canntab Therapeutics stands at 0.0001, as last reported on the 13th of December 2024, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. We have found three technical indicators for Canntab Therapeutics Limited, which you can use to evaluate the volatility of the firm.
  
Canntab Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
CTABF
Based on monthly moving average Canntab Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Canntab Therapeutics by adding Canntab Therapeutics to a well-diversified portfolio.

Canntab Therapeutics Valuation on November 25, 2024

It is possible to determine the worth of Canntab Therapeutics on a given historical date. On November 25, 2024 Canntab was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Canntab Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Canntab Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Canntab Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Canntab Therapeutics' related companies.
 Open High Low Close Volume
  0.0001    0.0001    0.0001    0.0001    1.00  
11/25/2024
  0.0001    0.0001    0.0001    0.0001    1.00  
  0.0001    0.0001    0.0001    0.0001    1.00  
Backtest Canntab Therapeutics  |  Canntab Therapeutics History  |  Canntab Therapeutics Valuation   PreviousNext  
Open Value
1.0E-4
1.0E-4
Closing Value
0.00
Upside

Canntab Therapeutics Trading Date Momentum on November 25, 2024

On November 26 2024 Canntab Therapeutics Limited was traded for  0.0001  at the closing time. The highest daily price throughout the period was 0.0001  and the lowest price was  0.0001 . There was no trading activity during the period 1.0. Lack of trading volume on 11/26/2024 did not affect price variability. The overall trading delta to current closing price is 0.00% .

Canntab Therapeutics Fundamentals Correlations and Trends

By evaluating Canntab Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Canntab Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Canntab financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Canntab Therapeutics Pink Sheet history

Canntab Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Canntab is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Canntab Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Canntab Therapeutics stock prices may prove useful in developing a viable investing in Canntab Therapeutics
Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada. Canntab Therapeutics Limited is headquartered in Markham, Canada. Canntab Therapeutics is traded on OTC Exchange in the United States.

Canntab Therapeutics Pink Sheet Technical Analysis

Canntab Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Canntab Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Canntab Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Canntab Therapeutics Period Price Range

Low
December 13, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Canntab Therapeutics Limited cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Canntab Therapeutics December 13, 2024 Market Strength

Market strength indicators help investors to evaluate how Canntab Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Canntab Therapeutics shares will generate the highest return on investment. By undertsting and applying Canntab Therapeutics pink sheet market strength indicators, traders can identify Canntab Therapeutics Limited entry and exit signals to maximize returns

Complementary Tools for Canntab Pink Sheet analysis

When running Canntab Therapeutics' price analysis, check to measure Canntab Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Canntab Therapeutics is operating at the current time. Most of Canntab Therapeutics' value examination focuses on studying past and present price action to predict the probability of Canntab Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Canntab Therapeutics' price. Additionally, you may evaluate how the addition of Canntab Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stocks Directory
Find actively traded stocks across global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume